Amoy Diagnostics Archives - Inside Precision Medicine

Inside Precision Medicine AmoyDx to Develop CDx for CANbridge Glioblastoma Candidate

Amoy Diagnostics (AmoyDx) will partner with CANbridge Life Sciences to develop a companion diagnostic for CANbridge’s lead candidate

Molecular Dx

AmoyDx to Develop CDx for CANbridge Glioblastoma Candidate

May 16, 2017

Source: © Dana Britton/Fotolia

Molecular Dx

Amoy Diagnostics, Illumina Join Hands for NGS Cancer Diagnostics in China

October 1, 2015

Related Content

New Research Pinpoints Mechanism Behind MYC Protein Production in Cancer

New Research Pinpoints Mechanism Behind MYC Protein Production in Cancer

Allogeneic NK Cells Are Coming to Beat Cancer at a Clinic Near You

Allogeneic NK Cells Are Coming to Beat Cancer at a Clinic Near You

Biomarkers of Immunotherapy Response: Current State-of-the-Art and Emerging Trends

Biomarkers of Immunotherapy Response: Current State-of-the-Art and Emerging Trends

Dana-Farber Scientists Develop PET Probe to Image Inflammation with High Sensitivity

Dana-Farber Scientists Develop PET Probe to Image Inflammation with High Sensitivity